Thermo Fisher Below Street Expectation, Lowers Annual Guidance Citing 'Macroeconomic Environment'

By Vandana Singh

Thermo Fisher Scientific Inc (NYSE: TMO) has posted Q2 revenue of $10.69 billion, down 3% Y/Y, missing the consensus of $10.98 billion .

Organic revenue was 3% lower, Core organic revenue growth was 2%, and COVID-19 testing revenue was $0.08 billion .

Revenue from Lif

You are viewing a robot-friendly page.Click hereto reload in standard format.